Leone John R Insider Trades

Insider Trading History

Track insider trading activity for Leone John R. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $216 15,000 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221M 15,000 shares
$14,715.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $108 7,473 shares
Last Trade
May 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$87.1M 4,138 shares
$21,060.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $576 40,000 shares
Last Trade
Jun 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49B 40,000 shares
$37,260.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $461 32,000 shares
Last Trade
Dec 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.61B 47,000 shares
$34,182.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $0 0 shares
Last Trade
Nov 21, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$329k 13 shares
$25,272.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $17.5 1,212 shares
Last Trade
Nov 21, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$16.4M 650 shares
$25,272.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $187 13,000 shares
Last Trade
Feb 13, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.89B 13,013 shares
$221,940.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $216 15,000 shares
Last Trade
Aug 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.77B 19,348 shares
$298,080.00
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $1.39k 96,623 shares
Last Trade
Aug 14, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.5B 31,667 shares
$1,089,075.45
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $1.15k 79,956 shares
Last Trade
Jul 22, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$123B 100,000 shares
$1,227,478.80
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $431 29,956 shares
Last Trade
Jun 18, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144B 37,222 shares
$3,879,831.30
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $216 15,000 shares
Last Trade
Jun 11, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.7B 19,734 shares
$3,834,453.18
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $43.2 3,000 shares
Last Trade
Feb 19, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.1B 3,000 shares
$6,375,629.22
$0.01
Windtree Therapeutics
Windtree Therapeutics WINT
Director
Holding Value $432 30,000 shares
Last Trade
Nov 13, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135B 30,000 shares
$4,515,125.34
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up